Results 21 to 30 of about 68,966 (291)

The Role of Follicular Fluid Thiol/Disulphide Homeostasis in Polycystic Ovary Syndrome

Balkan Medical Journal, 2018
Background: Oxidative stress has been proposed as a potential trigger in the etiopathogenesis of polycystic ovary syndrome-related infertility. Thiol/disulphide homeostasis, a recently identified oxidative stress marker, is one of the antioxidant ...
Esra Nur Tola, Nadiye Köroğlu, Merve Ergin, Hilmi Baha Oral, Abdülkadir Turgut, Özcan Erel   +5 more
doaj   +1 more source

The role of cholecalciferol deficiency in the pathogenesis of polycystic ovary syndrome

Women's Health, 2020
Objectives: to evaluate and compare clinical presentations, medical history, and laboratory data of patients with polycystic ovary syndrome, including vitamin 25(OH)D3 level. Methods: In total, 81 patients were examined.
Aigul Safi, Mekan Orazov, Svetlana Kalinchenko   +2 more
doaj   +1 more source

Rodent Models of Polycystic Ovary Syndrome [PDF]

, 2013
Rodents are clearly valuable models for assessing disruption of fertility. The effects of different steroid treatments at different stages of reproductive life through from fetal to adult have been assessed for effects on fertility, ovarian morphology ...
Duncan, Colin, McNeilly, Alan S
core   +1 more source

Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome : a systematic review and meta-analysis [PDF]

, 2012
Aims/hypothesis FTO gene single nucleotide polymorphisms (SNPs) have been shown to be associated with obesity-related traits and type 2 diabetes. Several small studies have suggested a greater than expected effect of the FTO rs9939609 SNP on weight in ...
Lerchbaum, E., Straczkowski, M., Malecki, MT, Vcelak, J, Tan, S., Wojciechowski, Piotr, B. Obermayer-Pietsch, Bendlova, B., Grigorescu, F., McCarthy, M. I., S. Franks, Lerchbaum, E, Lipowska, A, Rys, P., Hinney, A, Goodarzi, M. O., Azziz, R., Straczkowski, M, Bendlova, B, P. Lukasova, S. Tan, Azziz, Ricardo, McCarthy, Mark, F. Grigorescu, P. Rys, M. T. Malecki, Lukasova, P, J. Vcelak, M. I. McCarthy, null null, Attaoua, R, M. O. Goodarzi, Ewens, KG, B. Bendlova, Małecki, Maciej, Rys, P, Strauss III, J. F., Franks, S., Lukasova, P., Wojciechowski, P, McCarthy, MI, M. Straczkowski, R. Azziz, Strauss, JF, A. Lipowska, K. G. Ewens, Kowalska, I., Malecki, M. T., Barber, TM, Obermayer-Pietsch, B., Attaoua, R., R. Attaoua, Strauss III, JF, Grigorescu, F, J. F. Strauss, Tan, S, Kowalska, I, Wojciechowski, P., Barber, T. M., Ewens, K. G., Hinney, A., Strauss, J. F., III, P. Wojciechowski, McCarthy, Mark I., Vcelak, J., E. Lerchbaum, Goodarzi, MO, HASH(0x55a680537f60), Franks, S, Obermayer-Pietsch, B, T. M. Barber, I. Kowalska, Lipowska, A., A. Hinney, Azziz, R   +74 more
core   +1 more source

Polycystic ovary syndrome [PDF]

BMJ, 2011
Independently increases the risk of adverse pregnancy and birth outcomes Polycystic ovary syndrome is a common condition. The reported incidence varies between 3% and 15% of women of reproductive age, depending on the population studied and the diagnostic criteria applied,1 which include hyperandrogenism, anovulation, and polycystic ovaries.
openaire   +3 more sources

Variations of Steroid Hormone Metabolites in Serum and Urine in Polycystic Ovary Syndrome after Nafarelin Stimulation: Evidence for an Altered Corticoid Excretion. [PDF]

, 1995
To evaluate the clinical relevance of testing pituitary-ovarian responses in patients suffering from polycystic ovary syndrome (PCOS) with the GnRH agonist nafarelin, a 1.2-mg dose of nafarelin was given intranasally to 19 women with PCOS and 15 healthy ...
Roger, Müller, Burkhardt, Höss, Cornelia, Burkhardt Moller, Jacob, Karl, Thomas Strowitzki, Michael M. Weber, Kimmig, Rainer, Weber, Michael M., Engelhardt, Dieter, Luppa, Peter, A. Lob, Peter Luppa, Dieter Engelhardt, Karl Jacob, Cornelia H, Rainer Kimmig, Strowitzki, Thomas, Lobo, Rogerio A.   +18 more
core   +1 more source

The Polycystic Ovary Syndrome and the Metabolic Syndrome: A Possible Chronobiotic-Cytoprotective Adjuvant Therapy

International Journal of Endocrinology, 2018
Polycystic ovary syndrome is a highly frequent reproductive-endocrine disorder affecting up to 8–10% of women worldwide at reproductive age. Although its etiology is not fully understood, evidence suggests that insulin resistance, with or without ...
Eduardo Spinedi, Daniel P. Cardinali
doaj   +1 more source

Does AMH Reflect Follicle Number Similarly in Women with and without PCOS? [PDF]

PLoS ONE, 2016
Increased Anti-Mullerian Hormone in polycystic ovary syndrome, may be due to overactive follicles rather than reflect antral follicle count.Does Anti-Mullerian Hormone reflect antral follicle count similarly in women with or without polycystic ovary ...
Sverre C Christiansen, Tina B Eilertsen, Eszter Vanky, Sven M Carlsen   +3 more
doaj   +1 more source

HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome

Journal of the Formosan Medical Association, 2019
Background/purpose: Genetic variant of HSD3B1 1245 is known to augment androgen production at peripheral tissue as skin. This study aimed to investigate whether women with polycystic ovary syndrome inheriting this variant exhibit specific androgenic ...
Yi-An Tu, Sung-Jan Lin, Pei-Lung Chen, Chia-Hung Chou, Chu-Chun Huang, Hong-Nerng Ho, Mei-Jou Chen   +6 more
doaj   +1 more source

Controversies in the diagnosis of polycystic ovary syndrome

Therapeutic Advances in Reproductive Health, 2020
Polycystic ovary syndrome is a common endocrinological condition which is found to be prevalent in 5–10% of women of reproductive age. Historically, a combination of anovulation and androgen excess was considered a hallmark in the diagnosis of polycystic
Preetham Rao, Priya Bhide
doaj   +1 more source